Funding for this research was provided by:
National Institutes of Health (HL072705, HL078522, HL053392, CA127642, CA068484, HD052104, AI50274, HD052102, HL087708, HL079233, HL004537, HL087000, HL007188, HL094100, HL095127, HD80002, HD028820)
Roche Diagnostics (n/a)
Children's Cardiomyopathy Foundation (n/a)
Sofia’s Hope, Inc (n/a)
the Kyle John Rymiszewski Foundation (n/a)
the Children’s Hospital of Michigan Foundation (n/a)
the Scott Howard Fund (n/a)
the Michael Garil Fund (n/a)
Received: 2 May 2019
Accepted: 16 October 2019
First Online: 2 December 2019
Ethics approval and consent to participate
: Not applicable (review article).
: Not applicable.
: Rudolf Steiner: Oncology Consultant to Clinigen Group PLC, UK.Steven Lipshultz: Cardiology Consultant to Clinigen Group PLC, UK.Rest of the Authors: None.